Literature DB >> 23457299

The Legionella pneumophila Dot/Icm-secreted effector PlcC/CegC1 together with PlcA and PlcB promotes virulence and belongs to a novel zinc metallophospholipase C family present in bacteria and fungi.

Philipp Aurass1, Maren Schlegel, Omar Metwally, Clare R Harding, Gunnar N Schroeder, Gad Frankel, Antje Flieger.   

Abstract

Legionella pneumophila is a water-borne bacterium that causes pneumonia in humans. PlcA and PlcB are two previously defined L. pneumophila proteins with homology to the phosphatidylcholine-specific phospholipase C (PC-PLC) of Pseudomonas fluorescens. Additionally, we found that Lpg0012 shows similarity to PLCs and has been shown to be a Dot/Icm-injected effector, CegC1, which is designated here as PlcC. It remained unclear, however, whether these L. pneumophila proteins exhibit PLC activity. PlcC expressed in Escherichia coli hydrolyzed a broad phospholipid spectrum, including PC, phosphatidylglycerol (PG), and phosphatidylinositol. The addition of Zn(2+) ions activated, whereas EDTA inhibited, PlcC-derived PLC activity. Protein homology search revealed that the three Legionella enzymes and P. fluorescens PC-PLC share conserved domains also present in uncharacterized fungal proteins. Fifteen conserved amino acids were essential for enzyme activity as identified via PlcC mutagenesis. Analysis of defined L. pneumophila knock-out mutants indicated Lsp-dependent export of PG-hydrolyzing PLC activity. PlcA and PlcB exhibited PG-specific activity and contain a predicted Sec signal sequence. In line with the reported requirement of host cell contact for Dot/Icm-dependent effector translocation, PlcC showed cell-associated PC-specific PLC activity after bacterial growth in broth. A PLC triple mutant, but not single or double mutants, exhibited reduced host killing in a Galleria mellonella infection model, highlighting the importance of the three PLCs in pathogenesis. In summary, we describe here a novel Zn(2+)-dependent PLC family present in Legionella, Pseudomonas, and fungi with broad substrate preference and function in virulence.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23457299      PMCID: PMC3630882          DOI: 10.1074/jbc.M112.426049

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  96 in total

1.  Involvement of the twin-arginine translocation system in protein secretion via the type II pathway.

Authors:  R Voulhoux; G Ball; B Ize; M L Vasil; A Lazdunski; L F Wu; A Filloux
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

2.  Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU.

Authors:  A M Saliba; D O Nascimento; M C A Silva; M C Assis; C R M Gayer; B Raymond; M G P Coelho; E A Marques; L Touqui; R M Albano; U G Lopes; D D Paiva; P T Bozza; M C Plotkowski
Journal:  Cell Microbiol       Date:  2005-12       Impact factor: 3.715

3.  Conjugative transfer by the virulence system of Legionella pneumophila.

Authors:  J P Vogel; H L Andrews; S K Wong; R R Isberg
Journal:  Science       Date:  1998-02-06       Impact factor: 47.728

4.  Structure of Francisella tularensis AcpA: prototype of a unique superfamily of acid phosphatases and phospholipases C.

Authors:  Richard L Felts; Thomas J Reilly; John J Tanner
Journal:  J Biol Chem       Date:  2006-08-09       Impact factor: 5.157

Review 5.  Characterisation of Legionella pneumophila phospholipases and their impact on host cells.

Authors:  Christina Lang; Antje Flieger
Journal:  Eur J Cell Biol       Date:  2011-02-20       Impact factor: 4.492

6.  Pathogen effector protein screening in yeast identifies Legionella factors that interfere with membrane trafficking.

Authors:  Nadim Shohdy; Jem A Efe; Scott D Emr; Howard A Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

7.  Involvement of the Arg-Asp-His catalytic triad in enzymatic cleavage of the phosphodiester bond.

Authors:  R J Kubiak; X Yue; R J Hondal; C Mihai; M D Tsai; K S Bruzik
Journal:  Biochemistry       Date:  2001-05-08       Impact factor: 3.162

8.  Legionella pneumophila pathogenesis in the Galleria mellonella infection model.

Authors:  Clare R Harding; Gunnar N Schroeder; Stuart Reynolds; Artemis Kosta; James W Collins; Aurélie Mousnier; Gad Frankel
Journal:  Infect Immun       Date:  2012-05-29       Impact factor: 3.441

9.  Characterization and sequencing of a respiratory burst-inhibiting acid phosphatase from Francisella tularensis.

Authors:  T J Reilly; G S Baron; F E Nano; M S Kuhlenschmidt
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

10.  bdhA-patD operon as a virulence determinant, revealed by a novel large-scale approach for identification of Legionella pneumophila mutants defective for amoeba infection.

Authors:  P Aurass; B Pless; K Rydzewski; G Holland; N Bannert; A Flieger
Journal:  Appl Environ Microbiol       Date:  2009-05-01       Impact factor: 4.792

View more
  16 in total

1.  Life Stage-specific Proteomes of Legionella pneumophila Reveal a Highly Differential Abundance of Virulence-associated Dot/Icm effectors.

Authors:  Philipp Aurass; Thomas Gerlach; Dörte Becher; Birgit Voigt; Susanne Karste; Jörg Bernhardt; Katharina Riedel; Michael Hecker; Antje Flieger
Journal:  Mol Cell Proteomics       Date:  2015-11-06       Impact factor: 5.911

2.  Oligomerization inhibits Legionella pneumophila PlaB phospholipase A activity.

Authors:  Katja Kuhle; Joern Krausze; Ute Curth; Manfred Rössle; Klaus Heuner; Christina Lang; Antje Flieger
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

Review 3.  Bacterial Sphingomyelinases and Phospholipases as Virulence Factors.

Authors:  Marietta Flores-Díaz; Laura Monturiol-Gross; Claire Naylor; Alberto Alape-Girón; Antje Flieger
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

4.  LtpD is a novel Legionella pneumophila effector that binds phosphatidylinositol 3-phosphate and inositol monophosphatase IMPA1.

Authors:  Clare R Harding; Corinna Mattheis; Aurélie Mousnier; Clare V Oates; Elizabeth L Hartland; Gad Frankel; Gunnar N Schroeder
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

5.  Comparative analyses of Legionella species identifies genetic features of strains causing Legionnaires' disease.

Authors:  Laura Gomez-Valero; Christophe Rusniok; Monica Rolando; Mario Neou; Delphine Dervins-Ravault; Jasmin Demirtas; Zoe Rouy; Robert J Moore; Honglei Chen; Nicola K Petty; Sophie Jarraud; Jerome Etienne; Michael Steinert; Klaus Heuner; Simonetta Gribaldo; Claudine Médigue; Gernot Glöckner; Elizabeth L Hartland; Carmen Buchrieser
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

6.  Legionella pneumophila Effector LpdA Is a Palmitoylated Phospholipase D Virulence Factor.

Authors:  Gunnar N Schroeder; Philipp Aurass; Clare V Oates; Edward W Tate; Elizabeth L Hartland; Antje Flieger; Gad Frankel
Journal:  Infect Immun       Date:  2015-07-27       Impact factor: 3.441

7.  The Dot/Icm effector SdhA is necessary for virulence of Legionella pneumophila in Galleria mellonella and A/J mice.

Authors:  Clare R Harding; Charlotte A Stoneham; Ralf Schuelein; Hayley Newton; Clare V Oates; Elizabeth L Hartland; Gunnar N Schroeder; Gad Frankel
Journal:  Infect Immun       Date:  2013-05-06       Impact factor: 3.441

Review 8.  Subversion of Cell-Autonomous Immunity and Cell Migration by Legionella pneumophila Effectors.

Authors:  Sylvia Simon; Hubert Hilbi
Journal:  Front Immunol       Date:  2015-09-14       Impact factor: 7.561

9.  Use of Galleria mellonella as a model organism to study Legionella pneumophila infection.

Authors:  Clare R Harding; Gunnar N Schroeder; James W Collins; Gad Frankel
Journal:  J Vis Exp       Date:  2013-11-22       Impact factor: 1.355

Review 10.  Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing.

Authors:  Catherine Jia-Yun Tsai; Jacelyn Mei San Loh; Thomas Proft
Journal:  Virulence       Date:  2016-01-05       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.